| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6823112 | Schizophrenia Research | 2016 | 6 Pages |
Abstract
These results do not support a role for the mGluR-2 PAM AZD8529 as an antipsychotic and indicate that positive modulation of mGluR type 2 receptors alone is not sufficient for antipsychotic effects in acutely ill schizophrenia patients.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Robert E. Litman, Mark A. Smith, James J. Doherty, Alan Cross, Shane Raines, Lev Gertsik, Stephen R. Zukin,